Downregulation of miR-22 Contributes to Epithelial-Mesenchymal Transition in Osteosarcoma by Targeting Twist1

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• The epithelial-mesenchymal transition (EMT) is crucial for osteosarcoma (OS) metastasis.
• The molecular mechanisms regulating EMT in OS are not fully understood.
• MicroRNAs (miRNAs) are increasingly recognized as regulators of EMT.

Purpose of the Study:

• To investigate the role of miR-22 in regulating EMT in OS.
• To identify and validate the target of miR-22 involved in OS progression.
• To explore the therapeutic potential of targeting the miR-22/Twist1 pathway in OS.

Main Methods:

• Real-time PCR (qRT-PCR) to quantify miR-22 and Twist1 mRNA levels.
• Functional assays (proliferation, cell morphology) and Western blotting to assess miR-22 function.
• Luciferase reporter assay to confirm Twist1 as a direct miR-22 target.

Main Results:

• miR-22 levels were significantly decreased in OS tumors compared to normal tissue.
• Downregulation of miR-22 was associated with higher tumor histological grade.
• Overexpression of miR-22 inhibited OS cell proliferation and EMT.
• Twist1 was confirmed as a direct target of miR-22, with inverse correlation in patient samples.
• miR-22 suppressed Twist1 translation, attenuating EMT in OS cells.

Conclusions:

• miR-22 directly targets Twist1 to regulate EMT in osteosarcoma.
• The miR-22/Twist1 axis represents a potential therapeutic target for OS treatment.
• Restoring miR-22 levels may offer a novel strategy to combat OS metastasis.